Credit rating agency, Credit Analysis & Research (CARE) has assigned ‘A1+’ rating to the short term facilities of Wockhardt, having tenure of up to one year. Instruments with this rating are considered to have a strong degree of safety regarding timely payment of financial obligations and carry lowest credit risk.
Further, the credit rating agency has assigned a ‘AA-‘ rating to company’s long term facilities. Instruments with these ratings are considered to have a high degree of safety regarding timely servicing of financial obligations and such instruments carry very low credit risk.
Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.
